---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-070826"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2025-07-25T23:59:59+00:00"
generated_at: "2026-05-18T01:06:41.979389+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ReShape Lifesciences shareholders approve reverse split, stock issuance; asset sale vote postponed to Aug 7

## Summary
- Proposals 1,4,5,6 approved; meetings on asset sale (Prop 2) and merger charter (Prop 3) adjourned to Aug 7.
- Prop 1 (shares for merger) passed: 583,748 for, 59,520 against, 235,196 abstain, 604,121 broker non-votes.
- Prop 4 (reverse stock split 1:2 to 1:5) approved: 1,249,487 for, 227,492 against, 5,606 abstain.
- Reconvened meeting Aug 7 at 11:30am ET virtual; record date remains June 9, 2025.

## SEC filing metadata
- accession: 0001104659-25-070826
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2025-07-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465925070826/0001104659-25-070826-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465925070826/tm2521354d4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-070826
- JSON: https://secwatch.observer/filing/0001104659-25-070826.json
- Plain text: https://secwatch.observer/filing/0001104659-25-070826.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.